Krystal Biotech buy Chardan Capital
Start price
05.08.25
/
50%
€118.80
Target price
05.08.26
€189.46
Performance (%)
71.04%
Price
15:50
€203.20
Summary
This prediction is currently active. The BUY prediction by Chardan_Capital for Krystal Biotech has seen massive gains of 71.04%. This prediction currently runs until 05.08.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 8.522% | 8.522% |
| iShares Core DAX® | 1.917% | 1.088% |
| iShares Nasdaq 100 | 0.911% | 1.674% |
| iShares Nikkei 225® | 0.833% | -1.712% |
| iShares S&P 500 | 0.242% | 1.258% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat